This APA Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Monday
Avi Kapoor 7 months ago
NewsUpgradesPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Top Wall Street analysts upgraded APA Corp. & MoonLake Immunotherapeutics, see why & what other analysts think on our analyst ratings page.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Barclays analyst Betty Jiang upgraded APA Corporation (NASDAQ:APA) from Underweight to Equal-Weight and announced a $35 price target. APA shares closed at $39.11 on Friday. See how other analysts view this stock.
- Wolfe Research analyst Andy Chen upgraded MoonLake Immunotherapeutics (NASDAQ:MLTX) from Underperform to Outperform and raised the price target from $12 to $24. MoonLake shares closed at $16.27 on Friday. See how other analysts view this stock.
Considering buying APA stock? Here’s what analysts think:
Photo via Shutterstock